IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRγδ phenotype and absence of IL7Rα/CD127 expression

Leukemia

Volumn 18, Issue 12, 2004, Pages 1997-2001

  Asnafi, V ^a,d   Beldjord, K ^a,b   Garand, R ^c   Millien, C ^a,d   Bahloul, M ^a   LeTutour, P ^a   Douay, L ^b   Valensi, F ^a,d   Macintyre, Elizabeth ^a,d,e  

^a Hopitaux de Paris   (France)

^b CHU Nantes ^*

^c NANTES UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

CD127 IL7Ra; CD79a; IgH rearrangements; Lymphopoiesis; T ALL

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD7 ANTIGEN; CD79A ANTIGEN; CD79B ANTIGEN; HOX PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; RAG1 PROTEIN; RECEPTOR SUBUNIT; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CELL LINEAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE FREQUENCY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; INDIVIDUALIZATION; MAJOR CLINICAL STUDY; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 11144249294     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403531     Document Type: Article

References (26)

1. LeBien TW. Fates of human B-cell precursors. Blood 2000; 96: 9-23.
2. Benlagha K, Guglielmi P, Cooper MD, Lassoued K. Modifications of Igalpha and Igbeta expression as a function of B lineage differentiation. J Biol Chem 1999; 274: 19389-19396.
3. Dworzak MN, Fritsch G, Froschl G, Printz D, Gadner H. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny. Blood 1998; 92: 3203-3209.
4. Buccheri V, Mihaljevic B, Matutes E, Dyer MJ, Mason DY, Catovsky D. mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood 1993; 82: 853-857.
5. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995; 86: 1453-1459.
6. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783-1786.
7. Hashimoto M, Yamashita Y, Mori N. Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma/leukaemias. J Pathol 2002; 197: 341-347.
8. Finolezzi E, Corral L, Martelli MP, De Propris MS, Falini B, Cimino G. Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemia. Haematologica 2002; 87 ELT41.
9. Pilozzi E, Pulford K, Jones M, Muller-Hermelink HK, Falini B, Ralfkiaer E et al. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol 1998; 186: 140-143.
10. Lai R, Juco J, Lee SF, Nahirniak S, Etches WS. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias. Am J Clin Pathol 2000; 113: 823-830.
11. Davi F, Faili A, Gritti C, Blanc C, Laurent C, Sutton L et al. Early onset of immunoglobulin heavy chain gene rearrangements in normal human bone marrow CD34+ cells. Blood 1997; 90: 4014-4021.
12. Bertrand III FE, Billips LG, Burrows PD, Gartland GL, Kubagawa H, Schroeder Jr HW. Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow. Blood 1997; 90: 736-744.
13. Lassoued K, Nunez CA, Billips L, Kubagawa H, Monteiro RC, LeBlen TW et al. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell 1993; 73: 73-86.
14. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002; 99: 3892-3904.
15. Reynaud D, Lefort N, Manie E, Coulombel L, Levy Y. In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells. Blood 2003; 101 4313-4321.
16. Born W, White J, Kappler J, Marrack P. Rearrangement of IgH genes in normal thymocyte development. J Immunol 1988; 140: 3228-3232.
17. Szczepanski T, Pongers-Willemse MJ, Langerak AW, Harts WA, Wijkhuijs AJ, van Wering ER et al. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood 1999; 93: 4079-4085.
18. Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003; 101: 2693-2703.
19. Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood 2003; 102 1000-1006.
20. Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P et al. Age-related phenotypic and oncogenic differences in T-acute lymphoblastic leukemias may reflect thymic atrophy. Blood 2004, March 30 [E-pub ahead of print].
21. Zupo S, Isnardi L, Megna M, Massara R, Malavasi F, Dono M et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 1996; 88: 1365-1374.
22. Brumpt C, Delabesse E, Beldjord K, Davi F, Cayuela JM, Millien C et al. The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype. Blood 2000; 96: 2254-2261.
23. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257-2317.
24. Haks MC, Oosterwegel MA, Blom B, Spits HM, Kruisbeek AM. Cell-fate decisions in early T cell development: regulation by cytokine receptors and the pre-TCR. Semin Immunol 1999; 11: 23-37.
25. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20: 394-397.
26. Prieyl JA, LeBien TW. Interleukin 7 independent development of human B cells. Proc Natl Acad Sci USA 1996; 93: 10348-10353.